This IDC Market Perspective looks at how facial recognition deployments across Western Europe and how different legislative bodies are looking to deal with the technology. The pressure is growing on the European Union to implement controls around the use of facial recognition technology; this will have a significant impact on both vendors and end users of facial recognition systems. "The European Union is preparing to govern the use of facial recognition technology. Decisions made in the upcoming quarters could dramatically shape how facial recognition systems can be deployed and used in Western Europe. Businesses involved in either purchasing or supplying facial recognition systems need to seriously consider the type of legislation that might be introduced and how this would impact their strategies," said Jack Vernon, senior research analyst, European AI Systems.
Our reports have been used by over 10K customers, including:
The global nucleic acid isolation and purification market is projected to reach USD 9.2 billion by 2027 from USD 6.3billion in 2022, at a CAGR of 7.9% during the forecast period. The growth of this market can majorly be attributed to the increasing R&D activities as well as technological advancements and increasing automation. The emerging...
The chromatography resin market is estimated to grow to USD 3.8 billion by 2027 from USD 2.6 billion in 2022, at a CAGR of 8.0%. Chromatography is one of the most used analytical techniques in the quality testing and quality control of processed food products and various beverages. According to World Health Organization, food contamination...
The global epigenetics market is projected to reach USD 3.9 Billion by 2027 from USD 1.7 Billion in 2022, at a CAGR of 18.1% during the forecast period. Expanding non-oncology applications of epigenetics research is expected to open up new avenues of market expansion. Recent studies on epigenetics have been targeted toward periodontology,...
175 pages •
By The Business Research Company
• May 2022
Major players in the biostimulants market are BASF, Bayer CropScience, Novozymes A/S, Koppert Biological Systems, Verdesian Life Sciences, Lallemand Plant Care, Valagro, Syngenta, West Coast Marine Bio-Processing Corp, and Italpollina S.p.A. The global biostimulants market is expected to grow from $2.58 billion in 2021 to $2.85 billion...
The HPAPI market is projected to reach USD 39.6 Billion by 2027 from USD 24.5 billion in 2022, at a CAGR of 10.1% from 2022 to 2027. The market is driven by increasing demand for oncology drugs, growing demand for antibody-drug conjugates and others. The innovative HPAPIs segment is expected to account for the largest share...
The global tangential flow filtration market is projected to USD 2.8 billion by 2027 from USD 1.5 billion in 2022, at a CAGR of 13.2% during the forecast period. The rising advantages of tangential flow filtration over normal flow filtration, increasing adoption of single-use technologies, and growing R&D spending in pharma-biotech companies....
KEY FINDINGS The Europe immunoglobulin market is predicted to progress with a CAGR of 6.90% across the forecast period of 2022 to 2030. The regional market’s growth is fuelled by supportive government initiatives for immunoglobulin and plasma donation, the prevalence of different immunodeficiency diseases, and the growth...
The global ATP assays market is projected to reach USD 412 million by 2027 from USD 276 million in 2022, at a CAGR of 8.4%. The growth of this market can largely be attributed to the increasing food safety concerns, growing demand for ATP assays in pharmaceutical & biotechnology companies, rising investments in pharmaceutical & biotechnology...
The exosome research market is valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures. By...
KEY FINDINGS The Europe medical enzymes market is evaluated to grow with a CAGR of 5.86% during the forecasted period of 2022 to 2030. Key factors strengthening the regional market’s growth are the increasing demand for enzymes in the pharmaceutical sector, the rise in research and development activities, and the growing...
Tobacco
Pharmaceutical
Research And Development
Cardiovascular Disease
Biotechnology
Dietary Supplement
Europe
Gross Domestic Product
Tobacco Consumption
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.